Notices & Circulars
Start Date:
End Date:
Notice No:
Segment Name:
All
BSEHITECH
Commodity Derivatives
Currency Derivatives
Debt
Derivatives
EGR
Equity
General
IA/RA
Investment Advisers
IRD
Mutual Fund
NDS
Research Analysts
SLB
SME
SSE
Startups
Category Name:
All
Circulars Listed Companies
Company related
Compliance
Corporate Actions
Index
Others
Settlement/RMS
Tenders
Trading
Department:
All
Bad Delivery Cell
BSE Training Institute
BTI
Business Development
Business Operations
Clearing & Settlement
Corporate Communications
Corporate Relations
Corporate Secreterial
DAPM - General Administration
Datawarehouse Regulatory
Debt
Derivatives
DIS
DOSS
Economist Cell
ED's Office
Estate & Maintenance
Exchange Compliance
Finance & Accounts
Fixed Income
General Administration
Helpdesk
HR
Human Resources
ICC
Index Cell
Information Systems
Information Systems (Projects)
Information Technology
Inspection
Investors Services Cell
IPF Secretariat
ISMS
IT-Networks
IT-Operations
Legal
Listing Business Relationship
Listing Compliance
Listing Compliance-Monitoring
Listing Operations
Market Operations
Marketing
MD office
Member Institution Sales
Membership
Membership Compliance
Membership Services
Personnel
Post Trade
Premises Management
Regulatory Correspondence Dept.
S&P BSE Index
Secretarial
Security
SME
Surveillance
Tainted Shares
Trading Development
Trading Operations
Unified Business Commercial
Security Code/Name:
Subject:
Containing Text:
Notice No
Subject
Segment Name
Category Name
Department
PDF
20180308-23
Discontinuation of Trading and Delisting of equity shares of Claris Lifesciences Limited (Scrip Code: 533288)
Equity
Company related
Listing Operations
20180209-6
Offer to Buy – Acquisition Window (Delisting) for CLARIS LIFESCIENCES LTD – Activities Schedule
Equity
Trading
Trading Operations
20180208-2
Opening of Offer to Buy – Acquisition Window (Delisting) for Claris Lifesciences Limited
Equity
Trading
Listing Operations
20150521-11
Clarification received from the company on news article
Equity
Company related
DOSS
20140324-38
Tender Offer (Buyback) of Equity Shares of Claris Lifesciences Ltd.
Equity
Corporate Actions
Listing Compliance-Monitoring